Thursday, April 20, 2023
COVID-19 vaccine hesitancy, local trust and local studies
Pokee N, Yasri R. Long term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy. Adv Trop Med Pub Health Int. 2023; 13: 3 - 4.
ABSTRACT
In this short letter, the authors provide data on a long term follow-up of 13 cases of pediatric cases with neurocysticercosis who received long-term albendazole therapy. The long-term albendazole therapy is proven effective and safe. Also, the cessation of drug after being adult is also proven a valid practice.
ong term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy
Pokee N, Yasri R. Long term follow-up of pediatric cases with neurocysticercosis who received long-term albendazole therapy. Adv Trop Med Pub Health Int. 2023; 13: 3 - 4.
ABSTRACT
In this short letter, the authors provide data on a long term follow-up of 13 cases of pediatric cases with neurocysticercosis who received long-term albendazole therapy. The long-term albendazole therapy is proven effective and safe. Also, the cessation of drug after being adult is also proven a valid practice.
Langya henipavirus: the newest zoonotic virus threat
Pokee N, Zhao R. Langya henipavirus: the newest zoonotic virus threat. Adv Trop Med Pub Health Int. 2023; 13: 5 - 6.
ABSTRACT
In this short letter, the authors provide data on a new emerging infectious disease, Langya heniparvirus infection. The zoonosis possibility is discussed. The disease is a new public health problem to be concerned.
Key words: Langya henipavirus, emerging, zoonosis
Subscribe to:
Posts (Atom)